Considering that previous studies have suggested that the predictive power of CRP for adverse cardiovascular events may simply be due to its association with hyperglycemia, hypertension, and abnormal lipid metabolism, we adjusted for these factors in our final model. The gene discussed is CRP; the disease is hypertensive disorder.